DSM-5 cannabis withdrawal syndrome: Demographic and clinical correlates in U.S. adults

Ofir Livne, Dvora Shmulewitz, Shaul Lev-Ran, Deborah S. Hasin*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

60 Scopus citations

Abstract

Background: Cannabis withdrawal syndrome (CWS) was newly added to the Diagnostic and Statistical Manual of Mental Disorders in its most recent edition, DSM-5. With cannabis use increasing among U.S. adults, information is needed about the prevalence and correlates of DSM-5 CWS in the general population. This study presents nationally representative findings on the prevalence, sociodemographic and clinical correlates of DSM-5 CWS among U.S. adults. Method: Participants ≥18 years were interviewed in the National Epidemiologic Survey on Alcohol and Related Conditions-III (NESARC-III) in 2012-2013. Among the sub-sample of frequent cannabis users in the prior 12 months (≥3 times a week; N = 1527), the prevalence and demographic and clinical correlates of DSM-5 CWS were examined. Results: In frequent cannabis users, the prevalence of CWS was 12.1%. The most common withdrawal symptoms among those with CWS were nervousness/anxiety (76.3%), hostility (71.9%), sleep difficulty (68.2%) and depressed mood (58.9%). CWS was associated with significant disability (p < 0.001), and with mood disorders (adjusted odds ratios [aOR] = 1.9–2.6), anxiety disorders (aOR = 2.4–2.5), personality disorders (aOR = 1.7–2.2) and family history of depression (aOR = 2.5) but not personal history of other substance use disorders or family history of substance use problems. Conclusions: CWS is highly comorbid and disabling. Its shared symptoms with depressive and anxiety disorders call for clinician awareness of CWS and the factors associated with it to promote more effective treatment among frequent cannabis users.

Original languageEnglish
Pages (from-to)170-177
Number of pages8
JournalDrug and Alcohol Dependence
Volume195
DOIs
StatePublished - 1 Feb 2019

Funding

FundersFunder number
National Institute on Drug AbuseR01DA034244, R01DA018652
National Institute on Alcohol Abuse and Alcoholism
New York State Psychiatric Institute

    Keywords

    • Cannabis
    • Cannabis withdrawal
    • DSM-5
    • Epidemiology
    • Marijuana

    Fingerprint

    Dive into the research topics of 'DSM-5 cannabis withdrawal syndrome: Demographic and clinical correlates in U.S. adults'. Together they form a unique fingerprint.

    Cite this